Kurome Therapeutics closes $15 million Series A financing
Funding to develop targeted kinase inhibitors for treatment of hematopoietic cancers Kurome Therapeutics, a preclinical stage company dedicated to developing ...
Funding to develop targeted kinase inhibitors for treatment of hematopoietic cancers Kurome Therapeutics, a preclinical stage company dedicated to developing ...
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.